A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology

PLoS Neglected Tropical Diseases

Volumn 6, Issue 3, 2012, Pages

  Dang, Zhisheng ^a,b   Yagi, Kinpei ^c   Oku, Yuzaburo ^d   Kouguchi, Hirokazu ^c   Kajino, Kiichi ^a   Matsumoto, Jun ^e   Nakao, Ryo ^a   Wakaguri, Hiroyuki ^f   Toyoda, Atsushi ^g,h   Yin, Hong ^b   Sugimoto, Chihiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e NIHON UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g RIKEN YOKOHAMA INSTITUTE   (Japan)

^h NATIONAL INSTITUTE OF GENETICS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; RECOMBINANT TETRASPANIN 1; RECOMBINANT TETRASPANIN 3; RECOMBINANT VACCINE; TETRASPANIN; UNCLASSIFIED DRUG; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; GLYCOPROTEIN; HELMINTH ANTIBODY; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DRUG EFFICACY; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LIVER CYST; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PILOT STUDY; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LIVER; LIVER HYDATID CYST; MALE; NOSE MUCOSA; PARASITOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS MULTILOCULARIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREUND'S ADJUVANT; GLYCOPROTEINS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LIVER; MALE; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OLIGODEOXYRIBONUCLEOTIDES; PILOT PROJECTS; TETRASPANINS; VACCINES, SYNTHETIC;

EID: 84859179591     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001570     Document Type: Article

References (66)

1. Eckert J, Conraths FJ, Tackmann K, (2000) Echinococcosis: an emerging or reemerging zoonosis? Int J Parasitol 30: 1283-1294.
2. Mehlhorn H, Eckert J, Thompson RC, (1983) Proliferation and metastases formation of larval Echinococcus multilocularis, II. Ultrastructural investigations. Z Parasitenkd 69: 749-763.
3. Sakamoto T, Sugimura M, (1970) Studies on echinococcosis. XXIII. Electron microscopical observations on histogenesis of larval Echinococcus multilocularis. Jpn J Vet Res 18: 131-144.
4. Zhang W, Ross AG, McManus DP, (2008) Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol 181: 6679-6685.
5. Gottstein B, Haag K, Walker M, Matsumoto J, Mejri N, et al. (2006) Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol Int 55 (Suppl): S45-S49.
6. Vuitton DA, Gottstein B, (2010) Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. J Biomed Biotechnol 2010: 923193.
7. Vuitton DA, Zhang S, Yang Y, Godot V, Beurton I, et al. (2006) Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 55 (Suppl): S51-55.
8. Vuitton DA, (2003) The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85: 119-132.
9. Ortona E, Rigano R, Buttari B, Delunardo F, Ioppolo S, et al. (2003) An update on immunodiagnosis of cystic echinococcosis. Acta Trop 85: 165-171.
10. Riganò R, Profumo E, Ioppolo S, Notargiacomo S, Teggi A, et al. (1999) Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis. Clin ExpImmunol 115: 503-507.
11. Gottstein B, Mesarina B, Tanner I, Ammann RW, Wilson JF, et al. (1991) Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis). Am J Trop Med Hyg 45: 734-742.
12. Gottstein B, (1992) Echinococcus multilocularis infection: immunology and immunodiagnosis. Adv Parasitol 31: 321-380.
13. Gottstein B, Wunderlin E, Tanner I, (1994) Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57BL/6J) or resistant (C57BL/10) to secondary alveolar echinococcosis. Clin ExpImmunol 96: 245-252.
14. Rosenzvit MC, Camicia F, Kamenetzky L, Muzulin PM, Gutierrez AM, et al. (2006) Identification and intra-specific variability analysis of secreted and membrane-bound proteins from Echinococcus granulosus. Parasitol Int 55: S63-67.
15. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840.
16. Cai P, Bu L, Wang J, Wang Z, Zhong X, et al. (2008) Molecular characterization of Schistosoma japonicum tegument protein tetraspanin-2: Sequence variation and possible implications for immune evasion. Biochem Biophy Res Commun 372: 197-202.
17. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, et al. (2008) Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2: e308.
18. Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, et al. (2009) Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis. Vaccine 27: 7339-7345.
19. Batista-Duharte A, Lindblad EB, Oviedo-Orta E, (2011) Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett 203: 97-105.
20. Leroux-Roels G, (2010) Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine 28 (Suppl3): C25-36.
21. Krieg AM, Davis HL, (2006) CpG ODN as a Th1 immune enhancer for prophylactic and therapeutic vaccines. In: Hackett C, Harn DA, editors. Vaccine Adjuvants: Immunological and Clinical Principles Humana Press Inc., New Jersey, USA pp. 87-110.
22. Giddings OK, Eickhoff CS, Sullivan NL, Hoft DF, (2010) Intranasal vaccinations with the trans-sialidase antigen plus CpG adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infect Immun 78: 1333-1338.
23. Aldridge JR, Johnson EC, Kuhn RE, (2010) CpG stimulates protective immunity in BALB/cJ mice infected with larval Taenia crassiceps. J Parasitol 96: 920-928.
24. Kringel H, Dubey JP, Beshah E, Hecker R, Urban JF Jr, (2004) CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii. Vet Parasitol 123: 55-66.
25. Verthelyi D, (2006) Adjuvant properties of CpG oligonucleotides in primates. Methods Mol Med 127: 139-158.
26. Hartmann G, Weeratna RD, Ballas ZK, Payette P, Blackwell S, (2000) Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol 164: 1617-1624.
27. Borges O, Lebre F, Bento D, Borchard G, Junginger H, (2010) Mucosal vaccines: recent progress in understanding the natural barrier. Pharm Res 27: 211-223.
28. Harandi AM, Sanchez J, Eriksson K, Holmgren J, (2003) Recent developments in mucosal immunomodulatory adjuvants. Curr Opin Investig Drugs 4: 156-161.
29. Hopkins SA, Kraehenbuhl JP, Schodel F, Potts A, Peterson D, et al. (1995) A recombinant Salmonella typhimurinum vaccine induces local immunity by four different routes of administration. Infect Immun 63: 3279-3286.
30. Wu H, Russell MW, (1993) Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 61: 314-322.
31. Tsuji N, Suziki K, Kasuga-Aoki H, Matsumoto Y, Arakawa T, (2001) Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice. Infect immune 69: 7285-7292.
32. Tsuji N, Suzuki K, Kasuga-Aoki H, Isobe T, Arakawa T, (2003) Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infect Immun 71: 5314-5323.
33. McGuire C, Chan WC, Wakelin D, (2002) Nasal immunization with homogenate and peptide antigens induces protective immunity against Trichinella spiralis. Infect Immun 70: 149-152.
34. Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R, (1999) Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni. Infect Immun 67: 4360-4366.
35. Carol H, Nieto A, Villacres-Eriksson M, Morein B, (1997) Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes. Parasute Immunol 19: 197-205.
36. Harn DA, Mitsuyama M, Huguenel ED, David JR, (1985) Schistosoma mansoni: Detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites. J Immunol 135: 2115-2120.
37. Moribe H, Yochem J, Yamada H, Tabuse Y, Fujimoto T, et al. (2004) Tetraspanin protein (TSP-15) is required for epidermal integrity in Caenorhabditis elegans. J Cell Sci 117: 5209-5220.
38. Levy S, Shoham T, (2005) Protein-protein interactions in the tetraspanin web. Physiology (Bethesda) 20: 218-224.
39. Loukas A, Tran M, Pearson MS, (2007) Schistosome membrane proteins as vaccines. Int J Parasitol 37: 257-263.
40. Dang Z, Watanabe J, Kajino K, Oku Y, Matsumoto J, et al. (2009) Molecular cloning and characterization of a T24-like protein in Echinococcus multilocularis. Mol Biochem Parasitol 168: 117-119.
41. Da'dara AA, Skelly PJ, Wang MM, Harn DA, (2001) Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20: 359-369.
42. Da'dara AA, Li Y, Xiong T, Zhou J, Williams GM, et al. (2008) DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 26: 3617-3625.
43. Zhu Y, Ren J, Da'dara A, Harn D, Xu M, et al. (2004) The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is inhanced with IL-12. Vaccine 23: 78-83.
44. Machado AV, Cardoso JE, Claser C, Rodrigues MM, Gazzinelli RT, et al. (2006) Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase. Hum Gene Ther 17: 898-908.
45. Tewary P, Sukumaran B, Saxena S, Madhubala R, (2004) Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen. Vaccine 22: 3053-3060.
46. Mazumder S, Maji M, Das A, Ali N, (2011) Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice. PLoS One 6 (2): e14644.
47. McCluskie MJ, Weeratna RD, Payette PJ, Davis HL, (2001) The potential of CpG oligodeoxynucleotides as mucosal adjuvants. Crit Rev Immunol 21: 103-120.
48. Zimmermann S, Dalpke A, Heeg K, (2008) CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections. Int J Med Microbiol 298: 39-44.
49. Heath DD, Holcman B, Shaw RJ, (1994) Echinococcus granulosus: the mechanism of oncosphere lysis by sheep complement and antibody. Int J Parasitol 24: 929-935.
50. Gupta S, Garg NJ, (2010) Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice. PLoS Negl Trop Dis 4 (8): e797.
51. Park AY, Scott P, (2001) Il-12: keeping cell-mediated immunity alive. Scand J Immunol 53: 529-532.
52. Romani L, Pucetti P, Bistoni F, (1997) Interleukin-12 in infectious diseases. Clin Microbiol Rev 10: 611-636.
53. Zhang S, Hüe S, Sène D, Penfornis A, Bresson-Hadni S, et al. (2008) Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites? J Infect Dis 197: 1341-1349.
54. Vuitton DA, (2003) The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85: 119-132.
55. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
56. Rigano R, Buttari B, Profumo E, Ortona E, Delunardo F, et al. (2007) Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. Infect Immun 75: 1667-1678.
57. Eckmann L, (2003) Mucosal defences against Giardia. Parasite Immunol 25: 259-270.
58. Inaba T, Sato H, Kamiya H, (2003) Monoclonal IgA antibody-mediated expulsion of Trichinella from the intestine of mice. Parasitology 126 (Pt 6): 591-598.
59. Pater C, Müller V, Harraga S, Liance M, Godot V, et al. (1998) Intestinal and systemic humoral immunological events in the susceptible BALB/c mouse strain after oral administration of Echinococcus multilocularis eggs. Parasite Immunol 20: 623-629.
60. Woof JM, Kerr MA, (2006) The function of immunoglobulin A in immunity. J Pathol 208: 270-282.
61. Kilian M, Mestecky J, Russell MW, (1988) Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev 52: 296-303.
62. Underdown BJ, Schiff JM, (1986) Immunoglobulin A strategic defense initiative at the mucosal surface. Annu Rev Immunol 4: 389-417.
63. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ, (1989) IgA-induced eosinophil degranulation. J Immunol 142: 2393-2400.
64. Sardinha LR, Mosca T, Elias RM, do Nascimento RS, Gonçalves LA, et al. (2010) The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice. PLoS Negl Trop Dis 4 (1): e578.
65. Gottstein B, Felleisen R, (1995) Protective immune mechanisms against the metacestode of Echinococcus multilocularis. Parasitol Today 11: 320-326.
66. Mutwiri GK, Nichani AK, Babiuk S, Babiuk LA, (2004) Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J Control Release 97: 1-17.